Data from the PARTNER trials were assessed regarding post-procedural prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement and surgical aortic valve replacement. The timing and rates of PVE were similar between the groups, and they had a similar high mortality.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
November 7, 2019
October 29, 2019
In this intraoperative video, the authors demonstrate the principles of the BASILICA technique in an instance where redo-surgical aortic valve replacement was the appropriate management strategy.
October 17, 2019
Filmed at the STS Structural Heart Symposium in Chicago, Illinois, David Fullerton moderates a discussion on surgical training for transcatheter aortic valve replacement.
Transcatheter or Surgical Repair for Degenerative Mitral Regurgitation in Elderly Patients: A Propensity-Weighted Analysis
October 6, 2019
The authors address appropriate use of the transcatheter clip to treat degenerative mitral regurgitation in elderly low to moderate risk patients.
Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Surgical Prosthesis: What Does the Science Say in 2019?
September 4, 2019
E. Murat Tuzcu of Cleveland Clinic Abu Dhabi in the United Arab Emirates and Ourania Preventza of Baylor College of Medicine in Houston, Texas, discuss valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement.
Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement
August 29, 2019
Using an approach that minimizes valve depth relative to the membranous septum, the authors reduced the need for permanent pacemaker placement to a reliable and predictable 3% compared to the accepted standard of 10%.
August 25, 2019
In an era of increased use of MitraClip, surgical mitral valve repair still offers a durable solution. Tirone David and colleages report 1,234 consecutive patients who had mitral valve repair with 20 year follow-up.
August 16, 2019
The FDA-approved use of TAVR has now expanded to low-risk patients with severe aortic stenosis. This includes both Edwards Lifesciences' Sapien 3 and Sapien 3 Ultra as well as Medtronic's Evolut R and Evolut PRO.
August 14, 2019
Filmed at the Heart Valve Society Annual Meeting 2019 in Sitges, Spain, Sir Magdi Yacoub and Patrick Serruys discuss the future of tissue engineered valves.
In Global News: Lung Cancer Screening Eligibility, Geriatric Surgery Care Standards, and Studying Venom for Cardiac Protection
July 26, 2019
Patient Care and General Interest